Full-dose pemetrexed plus cisplatin combined with concurrent thoracic radiotherapy for previously untreated advanced nonsquamous non-small cell lung cancer-Reference-Cited by-同舟云学术

Full-dose pemetrexed plus cisplatin combined with concurrent thoracic radiotherapy for previously untreated advanced nonsquamous non-small cell lung cancer

Published:2015-04 Issue:4 Volume:26 Page:456-463
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Zhang Qin,Cai Xu-Wei,Zhu Zheng-Fei,Yu Wen,Liu Qi,Feng Wen,Xue Meng-Chen,Fu Xiao-Long

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference47 articles.

1. Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey.;Morgensztern;J Thorac Oncol,2010

2. . First-line systemic therapy practice patterns and concordance with NCCN guidelines for patients diagnosed with metastatic NSCLC treated at NCCN institutions.;Zornosa;J Natl Compr Canc Netw,2012

3. . 2011 Focused Update of 2009 American Society of Clinical Oncology clinical practice guideline update on chemotherapy for stage IV non-small-cell lung cancer.;Azzoli;J Clin Oncol,2011

4. First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review.;Goffin;J Thorac Oncol,2010

5. Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials.;Group;J Clin Oncol,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of thoracic tumor radiotherapy on survival in non‐small‐cell lung cancer with malignant pleural effusion treated with targeted therapy: Propensity score matching study;Cancer Medicine;2023-06-08

2. Non-Small Cell Lung Cancer with Malignant Pleural Effusion May Require Primary Tumor Radiotherapy in Addition to Drug Treatment;Cancer Management and Research;2022-11

3. Palliative thoracic radiation therapy for non-small cell lung cancer: 2018 Update of an American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline;Practical Radiation Oncology;2018-07

4. A phase I study of nedaplatin, pemetrexed and thoracic intensity-modulated radiotherapy for inoperable stage III lung adenocarcinoma;BMC Cancer;2016-10-07